Latest filing published 03 Apr 2020 for MESA LABORATORIES INC /CO/, €18k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +20.4%Entry US$20.24 · Close at T+365 US$24.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert Dwyer V: trading record in brief
Robert Dwyer V is a declared insider of Mesa Laboratories Inc /CO/, with filings sourced from SEC (Form 4). The record holds 67 filings, for trades running from 6 November 2006 to 3 April 2020.
Both buying and selling appear: 1 purchase worth €24k, against 26 sales worth €11.0M. The net balance comes to €10.9M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants and 33 option exercises. In 2020 alone, the filings show no purchases and 2 sales.
The latest filing, published on 3 April 2020, reports an option exercise of €917 in Mesa Laboratories Inc /CO/. The clock since the last published purchase (7 November 2006) now reads 7,306 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Dwyer V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200 shares@ US$97.781.0% of flowCommon StockSEC:0001228924-20-000008:0
- 200 shares@ US$122.661.2% of flowCommon StockSEC:0001228924-20-000008:1
- 90 shares@ US$142.400.6% of flowCommon StockSEC:0001228924-20-000008:2
- 172 shares@ US$89.700.8% of flowCommon StockSEC:0001228924-20-000007:0
- 17 shares@ US$58.510.0% of flowCommon StockSEC:0001228924-20-000007:1
- 189 shares@ US$70.560.7% of flowCommon StockSEC:0001228924-20-000007:2
- 1,367 shares@ US$258.7217.4% of flowCommon StockSEC:0001228924-20-000001:0
- 6,133 shares@ US$258.6278.3% of flowCommon StockSEC:0001228924-20-000001:1
- 150 shares0Common StockSEC:0001228924-19-000056:0
- 150 shares0Common StockSEC:0001228924-19-000042:0
- 250 shares@ US$29.200.2% of flowCommon StockSEC:0001228924-19-000033:0
- 500 shares@ US$50.500.5% of flowCommon StockSEC:0001228924-19-000033:1
- 750 shares@ US$51.850.8% of flowCommon StockSEC:0001228924-19-000033:2
- 400 shares@ US$122.661.0% of flowCommon StockSEC:0001228924-19-000036:0
- 90 shares@ US$142.400.3% of flowCommon StockSEC:0001228924-19-000036:1
- 753 shares@ US$70.561.1% of flowCommon StockSEC:0001228924-19-000035:0
- 600 shares@ US$97.781.2% of flowCommon StockSEC:0001228924-19-000035:1
- 856 shares@ US$89.701.6% of flowCommon StockSEC:0001228924-19-000034:0
- 68 shares@ US$58.510.1% of flowCommon StockSEC:0001228924-19-000034:1
- 30 shares0Common StockSEC:0001228924-19-000025:0
- 5,575 shares@ US$232.0022.4% of flowCommon StockSEC:0001228924-19-000006:0
- 342 shares@ US$232.001.4% of flowCommon StockSEC:0001228924-19-000007:0
- 2,356 shares@ US$235.059.5% of flowCommon StockSEC:0001228924-19-000004:0
- 1,727 shares@ US$235.007.0% of flowCommon StockSEC:0001228924-19-000004:1
- 150 shares0Common StockSEC:0001228924-18-000036:0
25 of 63 declarations
